Gyre Therapeutics GYRE
NASDAQ GYRE
$7.11 +0.11 (+1.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Gyre Therapeutics (GYRE) reported Return on Capital Employed [ROCE] of -10.97% for Q2 2026, down 14.94 percentage points from 3.97% a year earlier and down 8.31 percentage points from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Gyre Therapeutics posted Return on Capital Employed [ROCE] of 7.72%, down 8.21 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +80.43 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at 15.93% in FY2024 (+99.34 pp), -83.41% in FY2023 (-99.29 pp), 15.88% in FY2022 (+159.76 pp) and -143.88% in FY2021 (-71.17 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last three quarters, with an average year-over-year change of +32.60 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2023 (a gain of 298.55 percentage points); the low point was Q4 2023 (a drop of 175.77 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -2.66% (Q1 2026), 4.27% (Q4 2025) and 5.44% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Gyre Therapeutics 753.90 Mn 556.61 Mn 26.90 Mn -10.97%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.97%
Mar 31, 2026 -2.66%
Dec 31, 2025 4.27%
Sep 30, 2025 5.44%
Jun 30, 2025 3.97%
Mar 31, 2025 9.54%
Dec 31, 2024 15.28%
Sep 30, 2024 -70.25%
Jun 30, 2024 -63.84%
Mar 31, 2024 -65.96%
Dec 31, 2023 -155.61%
Sep 30, 2023 20.67%
Jun 30, 2023 -125.11%
Mar 31, 2023 68.07%
Dec 31, 2022 20.16%
Sep 30, 2022 20.43%
Jun 30, 2022 -15.15%
Mar 31, 2022 -230.48%
Dec 31, 2021 -166.04%
Sep 30, 2021 -118.53%
API Access

Gyre Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GYRE&period=max&api_key=YOUR_API_KEY